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ABSTRACT 
 
BACKGROUND: Since the introduction of Highly Active Anti-Retroviral Therapy and the dramatic 
improvement in the prognosis of individuals with Human Immunodeficiency Virus, liver disease due to 
chronic viral hepatitis has become as important cause of morbidity and mortality in co-infected 
individuals. The objective of the study was to determine the Sero-prevalence of Hepatitis B Virus, 
Hepatitis C Virus and Human Immunodeficiency Virus and the association of the virus with Hepatitis B 
Virus and Hepatitis C Virus infection. As Human Immunodeficiency Virus and Hepatitis B Virus 
infections are highly prevalent and they are among the major public health concern in developing 
countries including Ethiopia investigating this problem is of paramount benefit. Although studies on co-
infection of Hepatitis C Virus and Human Immunodeficiency Virus  have clearly identified adverse 
effects of co-infection, the prevalence of Hepatitis C Virus infection and the association with Human 
Immunodeficiency Virus in developing countries including Ethiopia has not been know for sure. 
METHOD: A cross sectional study was conducted from January 1 to 31, 2010, in Jimma University 
specialized hospital Blood Bank. The inclusion criteria of the study was adult who donated blood to 
Jimma University specialized hospital blood bank any time from establishment of the unit until January 
2010 and whose record was retrieved. Accordingly 9,204 adults were included of which 6,063 were 
selected by lottery method. Data on socio-demographic variables (age and sex), laboratory test result for 
Hepatitis B surface Antigen, anti- Hepatitis C Virus antibody, anti- Human Immunodeficiency Virus 1 
antibody, and Rapid Plasma Reagin tests were collected using structured questionnaire. After the data 
were collected, they were entered into a computer and analyzed using SPSS -16 for windows. P-Value of 
< 0.05 was taken to be statistically significant.  
RESULTS: The prevalence rate of Hepatitis B Virus, Hepatitis C Virus, Human Immunodeficiency 
Virus and syphilis infection were 2.1%, 0.2%, 2.1% and 0.7%, respectively. Sex and age had statistically 
significant association with Human Immunodeficiency and Hepatitis B virus infections where females 
were less likely to be infected. As age increases above 20 years, the risk of infection with Human 
Immunodeficiency Virus or Hepatitis B Virus increases. There was no association between Hepatitis B 
Virus, Hepatitis C Virus and Human Immunodeficiency Virus. 
CONCLUSION: the prevalence rate of Hepatitis B Virus, Hepatitis C Virus and Human 
Immunodeficiency Virus infections among blood donors in Jimma University specialized hospital were 
lower as compared to previous studies, in addition there was no association between Hepatitis B Virus, 
Hepatitis C Virus and Human Immunodeficiency Virus. Thus, community based study should be 
conducted to confirm the relationship of Hepatitis B Virus, Hepatitis C Virus and Human 
Immunodeficiency Virus. 
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INTRODUCTION 
 
Since the introduction of HAART and the 
dramatic improvement in the prognosis of 
individuals with HIV, liver disease due to chronic 
viral hepatitis has become an important cause of 
morbidity and mortality in co-infected individuals 
(1). This fact brought a serious concern about the 
growing problems of HIV/AIDS pandemic in sub 
Saharan Africa; where the transmission is 
predominantly through sexual route and most of 
the people in these region are already been 
exposed to HBV by the time they become 
sexually active to acquire HIV infection, with 
minority being exposed to both viruses more or 
less simultaneously (2, 3). Evidences indicate that 
HIV positive individuals are more likely to be 
infected with HBV, to be chronic carrier and have 
a higher HBV replication rate than HIV negative 
individuals. In addition, it is evident that 
immuno-suppression brought about by HIV 
infection may cause re-activation or re-infection 
in those previously exposed to HBV; further 
more HIV infection exacerbates liver disease in 
HBV co-infected individuals and there is an even 
greater risk of liver disease when HIV and HBV 
co-infected patients are treated with HAART (3). 
 
Most of the researches done on HIV and 
HBV co-infection have been conducted in areas 
of low HBV endemic regions where a number of 
studies carry similar ideas; a significant higher 
prevalence of HBV infection in HIV positive 
individuals. Studies done in sub-Saharan Africa 
have conflicting result; most of which don’t 
support an increase prevalence of HBV in HIV 
positive individuals (3, 4-9) and very few studies 
about HBV-HIV co-infection exist in Ethiopia. A 
case in point  is a study done on male blood 
donors appearing at the blood bank of a regional 
hospital in Northwest Ethiopia where the 
seroprevalence of HBsAG was 14.4% and  the 
prevalence of HIV infection was 16.7%  and 
there was no association between HIV and HBV 
infection(OR=0.79,95% CI=0.361.67) (10).     
Another study done in Addis Ababa found that: 
the prevalence of HBsAg and anti-HBc in VCT 
clients was 5.7% and 44.8%, respectively. 
Among HIV-infected persons, 3.9% were sero-
positive for HBsAg; and there was no significant 
difference in HBsAg or anti-HBc sero-positivity 
between HIV-positive and HIV-negative subjects. 
Anti-HBc positivity was significantly higher in 
men, among the age range 40-49 years, and in 
subjects with a history of catheterization (11). A 
comparative cross-sectional study in 
asymptomatic Ethiopian compared data on the 52 
people who were HIV positive with 139 who 
were HIV negative to examine HIV's 
relationships with treponemal infection and 
hepatitis B infection. The two groups were 
essentially the same age (37 years for cases and 
35.5 years for controls). No significant difference 
in the prevalence of hepatitis B virus (HBV) 
markers existed between the two groups (70% for 
HIV-positive migrants and 78.8% for HIV-
negative migrants), but HIV-positive migrants 
were more likely to have markers for hepatitis B 
surface antigen than HIV-negative migrants (20% 
vs. 8.6%; p=0.018). The HIV-positive migrants 
had a higher prevalence of treponemal markers 
than did HIV-negative migrants (31% vs. 3%), 
this finding was interpreted as indicating that 
treponemal disease increased their risk of HIV 
infection (12). 
 
   HIV and HCV share common mechanism of 
transmission (parental, sexual and mother to 
child).  This epidemiological similarity accounts 
for the high frequency of co-infection by HIV and 
HCV, which is common among patients with 
history of injectable drug use and blood 
transfusion (13, 14). Co-infection of HCV in 
HIV–infected patients have several implications 
for clinical care and management; firstly, HCV 
viral load is higher in people with HIV infection, 
the rate of progression of Hepatitis C infection to 
end stage liver disease is accelerated 3 fold in the 
presence of HIV infection and HCV infection is 
now a leading cause of hospitalization and death 
in this population (15, 16). Secondly hepatitis C 
increases the risk of hepato-toxicity with ART, 
particularly with drugs such as nevirapine, and so 
may affect the choice of therapy and timing (15, 
17). Thirdly, the use of HAART in HCV infected 
patients may precipitate HCV immune 
reconstitution phenomena, and there may also be 
impaired immune recovery in co-infected 
individuals (18, 19).  A multi center study done to 
assess HCV prevalence and predictors of HIV/ 
HCV co-infection has found that: HIV/HCV co-                                             Hepatitis B and C Viruses infection…                                    Alemeshet Y. et al 
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infection prevalence was 16.1%, which varied 
from 1.9% in South Africa to 48.6% in Italy. The 
strongest predictors of HIV/HCV co-infection 
was HIV exposure category (P< 0.001), the 
prevalence of HIV/HCV was low (3.7%) among 
homosexual men without reported IDU; this may 
suggest the low efficacy of sexual transmission of 
HCV (20).  Few studies about HCV-HIV co-
infection exist in sub-Saharan Africa. A study 
done in Kenya to determine the prevalence of 
HCV and HCV/HIV co-infection among medical 
inpatients found similar prevalence of HCV in 
both HIV positive and negative patients (3.7% Vs 
4.4 % respectively) (21). Another study done in 
Ethiopia to determine the prevalence of HCV in 
antenatal attendees and commercial sex workers 
found that the overall prevalence of HCV was 
1.8% peaking to 5.6% in 40-44 years old age 
group and HIV prevalence was 4.9%. Yet, sero-
prevalence of HCV was markedly increased in 
HIV infected sera that HIV negative samples 
(8.6% Vs 1.6%)(36). A study in Addis Ababa 
found that HCV antibody prevalence was 0.9% 
and higher among HIV-positive compared to 
HIV-negative individuals (4.5% vs. 0.8%, 
respectively, P < 0.001). Similar higher 
prevalence of HCV antibodies was seen among 
HIV-positive compared to HIV-negative 
antenatal care attendees (2.9% vs. 0.8%, 
respectively, P=0.003), and sex workers (5.3% 
vs. 1.3%, respectively, P=0.02). After 
stratification by HIV status, HCV prevalence 
among women of the general population was 
identical to that of sex workers, suggesting that 
HCV sexual transmission is not common in this 
population and that HIV infection does not 
enhance susceptibility to HCV sexual 
transmission (22). 
 
   As Human Immunodeficiency Virus and 
Hepatitis B Virus infections are highly prevalent 
and they are among the major public health 
concern in developing countries including 
Ethiopia, investigating this problem is of 
paramount benefit. Although studies on co-
infection of Hepatitis C Virus and Human 
Immunodeficiency Virus have clearly identified 
adverse effects of co-infection, the prevalence of 
Hepatitis C Virus infection and the association 
with Human Immunodeficiency Virus in 
developing countries including Ethiopia has not 
been know for sure.  This study was conducted in 
JUSH Blood Bank Unit to determine the sero-
prevalence of HBV, HCV and HIV and ascertain 
association of HIV infection with HBV and HCV 
infections in Ethiopia. Jimma University 
specialized Hospital (JUSH) is the only hospital 
in Jimma zone serving the majority of people 
living in Jimma town and its surrounding. JUSH 
provides both inpatient and outpatient services 
and as one of the inpatient services the hospital 
has blood bank unit. The Blood bank unit is 
established in 1987 and started functioning since 
1988. The unit is currently run by Jimma 
University specialized hospital in collaboration 
with Jimma Red Cross Society. Since the 
establishment of the unit, about 600 to 900 adults 
donate blood yearly.   
 
METHODS AND MATERIALS 
 
A cross-sectional study was conducted from 
January 1 to 31, 2010 in JUSH Blood Bank Unit. 
The unit receives and stores blood donated from 
adults either as replacement or voluntarily. 
Regular screening of blood donors is made before 
donation by in-depth interview for symptoms of 
disease and by measuring weight, blood pressure 
and hemoglobin level. Those adults who are 
apparently asymptomatic, weighing 50 Kg or 
more, with normal blood pressure and 
hemoglobin level donate blood. After collection 
of donated blood, samples are taken for screening 
of HIV, HBV and HCV infections using ELISA 
technique for anti HIV-1 antibody, HBsAG, and 
anti HCV-antibody respectively and Rapid 
Plasma Reagin (RPR) test for syphilis infection. 
If negative for all four serological tests mentioned 
above, the blood is stored in refrigerator and 
delivered for patient that needs blood transfusion.  
In the Unit every blood sample is given a unique 
code and recorded. Reports are also delivered to 
the hospital statistics office and finally to national 
level every month, quarterly, and annually. 
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The inclusion criterion was blood donated by an 
adult to the JUSH blood bank since the 
establishment of the unit until January 2010 and 
where the record could be retrieved. Accordingly 
9,204 adults were included of which 6,063 were 
selected by lottery method. Data on socio-
demographic variables (age and sex), laboratory 
test result for HBsAG, Anti- HCV antibody, HIV, 
and RPR were collected using structured 
questionnaire. After collection, the data was 
cleaned manually, categorized and coded finally 
entered in to a computer and analyzed using 
SPSS version 16.0 for windows. First, Univariate 
analysis was done to determine the frequency of 
positive serological test, then bivariate analysis 
was done to determine predictors for infection 
and finally multivariate analysis was done to 
determine independent predictors of infection 
using logistic regression model. P- Value < 0.05 
was taken to be statistically significant.  
 
Ethical clearance was obtained from Ethical 
Committee of Jimma University. To avoid the 
risk of back retrieval of confidential information 
like names of the donors, during data collection 
new code numbers were given by the principal 
investigator. After the necessary information was 
obtained, the code numbers on the questionnaires 
were deleted. 
 
RESULTS 
 
Of the total 6063 blood donors, males were 4802 
(79.2%) and 1261 (20.8%) were females. Their 
mean age was 26.7±8.6 years (range 18-67). The 
majority (91.6%) of donors were < 45years old 
and majority of them, 4102 (67.7%) donated 
blood from September 2008 to January 2010 
(Table 1). 
 
The prevalence rate of HBV, HCV, HIV and 
syphilis infection as evidence with positive 
serological test for HBsAG, anti HCV antibody, 
anti HIV- 1 antibody and RPR were 126 (2.1%), 
10 (0.2%), 129(2.1%), and 44(0.7%), respectively 
(Table 2). 
 
 
 
 
 
 
Table1. Base line characteristics of blood donors 
in JUSH, January 2010. 
 
 
Table 2. Serological test result of blood donors in 
JUSH, January 2010. 
 
          Variables   Status   Number (%) 
HBsAG 
 
Positive 126(2.1) 
Negative   5937(97.9) 
HIV Positive  129(2.1) 
Negative   5934(97.9) 
Anti –HCV 
antibody 
Positive 10(0.2) 
Negative   6053(99.8) 
RPR Positive  44(0.7) 
Negative   6019(99.3) 
     Total   6063(100.0) 
 
The overall prevalence rate of HIV infection in 
the study population was 2.1%.  One hundred 
nineteen (2.5%)  out of the 4802 males and 10 
(0.8%)  out of the 1261 females  were having 
HIV infection and analysis of HIV infection by 
age group revealed prevalence increases as age 
increases. The prevalence rate of HIV infection 
was higher in those who donated blood before 
          Variables    Number (%) 
Sex   Male   4802 (79.2) 
Female   1261 (20.8) 
Age <20  1472  (24.3) 
20-24 1856  (30.6) 
25-29 957  (15.8) 
30-34 957  (15.8) 
35-39 509  (8.4) 
40-44 509  (8.4) 
≥ 45  509 (8.4) 
Year of 
donation 
Before Sep. 2008  1961 (32.3) 
Sep.2008-Jan.2010 4102  (67.7) 
  Total   6063 (100.0)                        Hepatitis B and C Viruses infection…                                    Alemeshet Y. et al    
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September 2008 as compared to those who 
donated later; 47 of 1961 (2.4%) and 82 of 
4102(2.0%) respectively.  The prevalence rate of 
HIV was lower in those having HBV infection as 
compared to those without the infection; 2 of 126 
(1.6%) and 127 of 5937 (2.1%) respectively. On 
the other hand, none of the HIV positive blood 
donors had co-infection with HCV or syphilis. 
Furthermore, Bivariate analysis showed 
association of HIV infection with Sex and age, 
this association was also maintained on 
multivariate analysis. Accordingly, females were 
less likely to be infected with HIV as compared 
to males, adjusted OR = 0.381, 95%CI, (0.198, 
0.733).  As compared to those in the age group 
less than 20 years, those of age 20-29 years, 30-
34 years, 35-39 years and 40-44 years were two, 
four, five and eight times at increased risk of HIV 
infection ,respectively. There was no statistically 
significant difference in the prevalence of HIV 
infection among the age group less 20 years and 
those with age group of 45 years or more;   
adjusted OR = 0.315, 95%CI (0.040, 2.450). 
Furthermore, there was no association among 
year of donation, HCV infection, HBV infection 
and Syphilis with HIV infection (Table 3). 
 
Table 3. HIV infection in of blood donors in JUSH, January 2010. 
          Variables   Number (%)  HIV positive 
Number (%) 
P-value 
 
Crude OR 
(95%ci) 
Adjusted OR 
(95%ci) 
Sex     Male   4802(79.2)  119(2.5)  0.000  1   
Female 1261(20.8)  10(0.8)  0.315(0.164,  0.602)  0.381(0.198,0.733) 
Age <20  1472  (24.3)  11(0.7)  0.000  1   
20-24  1856(30.6)  33(1.8)  2.404(1.211, 4.774)  2.162(1.086, 4.302) 
25-29 957(15.8)  18(1.9)  2.546(1.197,  5.415)  2.193(1.027,4.681) 
30-34 957(15.8)  23(3.7)  5.049(2.446,10.423)  4.329(2.088,  8.973) 
35-39 509(8.4)  23(4.5)  6.286(3.042,12.988) 5.364(2.585,11.133) 
40-44 509(8.4) 20(6.8)  9.766(4.627,  20.613)  8.491(4.008,17.988) 
≥ 45  509(8.4)  1(0.3)  0.382(0.049,2.966)  0.315(0.040,2.450) 
Year of 
donation  
Before Sep. 
2008 
1961(32.3) 47(2.4)  0.315    
Sep.2008-
Jan.2010 
4102(67.7) 82(2.0)     
Anti HCV 
antibody 
Positive 10(0.2)  0(0.0)  0.625     
Negative   6053(99.8)  129(2.1)     
HBsAG Positive  126(2.1) 2(1.6)  0.671     
Negative   5937(97.9)  127(2.1)     
RPR Positive  44(0.7)  0(0.0) 0.326     
Negative   6019(99.3)  129(2.1)     
Total   6063(100.0)  129(2.1)       
 
The overall prevalence rate of HBV infection in 
the study population was 2.1% where 119 (2.5%) 
out of the 4802 of the males and seven (0.6%) of 
the 1261 females were having HBV infection. 
Analysis of HBV infection by age group showed 
highest prevalence in the age group 40-44 years 
and lowest among the age group of forty five 
years or more 13 of 509 (4.5%) and 3 of 509 
(0.9%) respectively. The prevalence rate of HBV 
infection was similar, 2.1% in those who donated                         Ethiop J Health Sci.                           Vol. 21, No.1                             March 2011 
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blood before September 2008 and in those who 
donated later. However, the prevalence rate of 
HBV is low in those having HIV infection as 
compared to those without the infection and only 
two of 129 (1.6%) of blood donors with HIV 
infection and 124 (2.4%) of blood donors without  
HIV infection were positive for HBV but the 
prevalence rate of HBV  was higher in those 
having Syphilis infection as compared to those 
without  it where two (4.5%) of  the 44 blood 
donors with Syphilis infection and 124 (2.1%) of 
6019 of blood donors without Syphilis infection 
were positive for HBV; yet, none of HBV 
positive blood donors had co-infection with 
HCV. Furthermore, Bivariate analysis revealed 
that sex and age had association with HBV 
infection where this had also been maintained on 
multivariate analysis. On the other hand, females 
were less likely to be infected with HBV as 
compared to males, adjusted OR = 0.243, 95%CI 
(0.112, 0.524). As compared to those in the age 
group less than 20 years, those with age group 
20-24 years, 30-34 years and 35-39 years were 
twice and those with age group 40-44 years were 
four times at increased risk of HBV infection, 
respectively. But there was no association 
between year of donation, HCV infection, HIV 
infection and syphilis with HBV infection (Table 
4). 
 
Table 4. HBV infection in blood donors in JUSH, January 2010. 
 
          Variables   Number (%)   Pos. for HBsAG 
Number (%) 
P-value  
 
Crude OR 
(95%CI) 
Adjusted  OR 
(95%CI) 
Sex     Male   4802(79.2)  119(2.5)  0.000  1   
Female 1261(20.8)  7(0.6)  0.220(0.102,0.472)  0.243(0.112,  0.524) 
Age <20  1472  (24.3)  14(1.0)  0.000  1   
20-24  1856(30.6)  48(2.6)  2.765(1.518, 5.034)  2.413(1.322, 4.404) 
25-29  957(15.8)  16(1.7)  1.771(0.860, 3.645)  1.462(0.708, 3.019) 
30-34  957(15.8)  18(2.9)  3.073(1.519, 6.218)  2.522(1.242, 5.121) 
35-39  509(8.4)  14(2.8)  2.945(1.394, 6.222)  2.402(1.133, 5.092) 
40-44 509(8.4) 13(4.5)  4.853(2.256,10.435)  4.049(1.877,  8.737) 
>_45 509(8.4)  3(0.9)  0.903(0.258,3.159)  0.706(0.201,  2.476) 
Year of 
donation  
Before 
Sep.2008 
1961(32.3) 41(2.1)  0.962 
Sep. 2008-
Jan.2010 
4102(67.7) 85(2.1) 
HIV Positive  129(2.1)  2(1.6)  0.671 
Negative   5934(97.9)  124(2.1) 
Anti –HCV 
antibody 
Positive 10(0.2)  0(0.0)  0.629 
Negative   6053(99.8)  126(2.1) 
RPR Positive  44(0.7)  2(4.5)  0.250 
Negative   6019(99.3)  124(2.1) 
Total   6063(100.0)  126(2.1)   
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The overall prevalence rate of HCV infection in 
the study population was 0.2% where nine (0.2%) 
of the 4802 males and 2 (0.2%) of the 1261 
females were having HCV infection. Analysis of 
HCV infection by age group showed no evidence 
of infection among the age group less than 20 
years, 20-24 years and in those 45 years or more, 
but higher prevalence was observed among the 
age group 30-34 years and 35-39 years, 3 of 957 
(0.5%) and 4 of 509 (0.8%), respectively. The 
prevalence rate of HCV infection was similar in 
those who donated blood before September 2008 
as compared to those who donated later 2 of 1961 
(0.1%) and 9 of 4102(0.2%), respectively. The 
prevalence rate of HCV is higher in those having 
syphilis infection as compared to those without 
the infection; one of 44 (2.3%) of blood donors 
with syphilis infection and 10 of 6019 (0.2 %) of 
blood donors without syphilis infection were 
positive for HCV but none of HCV positive blood 
donors had co-infection with HBV or HIV.   
Bivariate analysis showed association between 
syphilis and HCV infection, accordingly blood 
donors without serological evidence of syphilis 
infection were at lesser risk of having HCV 
infection as compared to those having serological 
evidence of syphilis infection, crude OR = 0.072, 
95%CI (0.009, 0.571). However, this association 
was not maintained on multivariate (Table 5).
 
Table 5. HCV infection of blood donors in JUSH, January 2010. 
          Variables   Number (%)   Post. for Anti 
HCV anti-body 
Number (%) 
P-value 
 
Crude OR 
(95%CI) 
Adjusted OR 
(95%CI) 
Sex     Male   4802(79.2)  9(0.2)  0.831     
Female 1261(20.8)  2(0.2)     
Age <20  1472  (24.3)  0(0.0)  0.951     
20-24 1856(30.6)  0(0.0)     
25-29 957(15.8) 3(0.3)     
30-34 957(15.8)  3(0.5)     
35-39 509(8.4)  4(0.8)     
40-44 509(8.4) 1(0.3)     
>_45 509(8.4) 0(0.0)     
Year of 
donation  
Before Sep. 
2008 
1961(32.3) 2(0.1)  0.315     
Sep.2008-
Jan.2010 
4102(67.7) 9(0.2)     
HBsAG 
 
Positive 126(2.1)  0(0.0)  0.629     
Negative   5937(97.9)  11(0.2)     
HIV Positive  129(2.1)  0(0.0)  0.625     
Negative   5934(97.9)  11(0.2)     
RPR Positive  44(0.7) 1(2.3)  0.013  1  1 
Negative   6019(99.3)  10(0.2)  0.072(0.009, 0.571)  0.140(0.017,1.162) 
Total   6063(100.0)  10(0.2)       
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DISCUSSION 
 
This study is the first in its kind in Ethiopia as it 
tried to ascertain association of HIV infection 
with HBV and HCV infections and was 
conducted in a large number of population; but as 
the study population are highly selected group; 
blood donors, conclusion might not be drawn to 
general population. The prevalence of HIV 
(2.1%) is lower than what had been reported by 
studies done on male blood donors (16.7%) (10), 
urban setting (5.5%) but higher than rural setting 
(0.7%) (23), the result is comparable to the 
prevalence among women attending antenatal 
clinics which was 1.9% in 2000, 2.6% in 2003 
and 2.2% in 2005 (24).  There was association 
between sex and HIV infection where women 
were less likely to be infected as compared to 
men; this is against the previous study which 
showed prevalence among adult women double 
that of men (23) this could be because the 
different study population used in the two studies 
(blood donors versus general population). This 
study revealed that as age increases above 20 
years, the risk of acquiring HIV increases but not 
for those 45 years or more, this might be because 
as age increases the risk of exposure to HIV 
increases, the absence of association in those 
more than 45 years could be because of the 
smaller number of individual in this age group, 
only 509 were in the age group as compared to in 
the age group 20-24 years, 1856. The study 
showed no association between HIV with HBV 
and HCV infections, this is in accordance to 
previous studies (10, 11, 21).   
The prevalence rate of HBV infection 
using ELISA for HBsAG was 2.1%, this is lower 
than previous study done on male blood donors 
which showed prevalence rate of 14.4%(10) and 
VCT clients that showed the prevalence rate of 
5.7%(11) this might be because the study 
population are highly selected, most of them 
could be volunteer blood donors and confident of 
their sero status. Multivariate analysis showed 
that association between sex and HBV infection 
exist, where females had lesser risk of infection 
as compared to males which is in accordance with 
previous study finding (11). This study revealed 
that as age increases above 20 years, the risk of 
acquiring of HBV increases as except for those 
age 45 years or more, which had no difference as 
compared to those age less than 20 years, this 
might be because as age increases the risk of 
exposure to HBV increases in parallel, the 
absence of association in those more than 45 
years could be because of the smaller number of 
individual in this age group as compared to 
others, only 509 were in the age group  as 
compared to  in the age group 20-24 years,1856. 
The prevalence rate of HCV infection is 
low (0.2%) as compared to previous studies (21, 
22, 25) this might be because the study 
population where most them were volunteer 
blood donors who were confident of their sero 
status. 
 
In conclusion, this study had shown that 
the prevalence rate of HBV, HCV and HIV 
infections as evidence with positive serological 
test for HBsAG, anti HCV antibody and anti HIV 
1 antibody among blood donors in JUSH was 
lower compared to previous studies.  The study 
also found no association between HBV or HCV 
infection with HIV. Thus, community based 
study should be conducted to ascertain the 
relationship of HBV or HCV infection with HIV. 
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